CENTURY SILK INC.

Cyient shares rally 9% after Q2 revenue rises 25%; board declares Rs 12/sh interim dividend

Cyient shares surged on Friday after the company reported a 25% year-on-year rise in consolidated revenue to Rs 2,235 crore in Q2 FY27. Net profit…

Nippon Silver ETF, other silver ETFs slide up to 4% as silver prices tumble. Here’s why

Silver ETFs tumble up to 4% as India permits 6,500 metric tonnes of silver imports over six months, raising expectations of easing domestic supply tightness…

Q2 Results Live Updates: Infosys, Tata Motors, Adani Power, JSW Steel in focus ahead of earnings today

₹25 per share dividend stock: Record date today - Check dividend payout details, history, yield and share returns

LTM interim dividend 2026 record date today: LTM share price fell over 2% to ₹4,190.10 per share on NSE amid dividend record date today, 23…

SRF's persistent pain point hampers investors' confidence on earnings outlook

The management reiterated its 15-20% revenue growth guidance for the chemicals business and expects to deliver at the higher end of the range in FY27

Safe-haven demand pushes Japan’s 10-year yield to two-month low

Japanese government bonds saw a rally on Friday, leading to the benchmark 10-year yield hitting a two-month low. This surge occurred in response to a…

Freaky Friday in stock market today: Sensex, Nifty reverse morning gains and crash for 3rd session — what led to blood?

Indian markets reversed early gains on Friday, with the Sensex and Nifty extending losses for a fourth session. Surging crude prices, Middle East tensions, global…

Karur Vysya Bank: Up 35% in YTD but down 6% today — What's slumping Rekha Jhunjhunwala stock? What's next for investors?

Rekha Jhunjhunwala portfolio stock Karur Vysya Bank has risen from around ₹269 to ₹335 per share on the NSE in YTD

Infinx plans $300 million IPO in India, appoints three bankers

Infinx Technology Solutions has appointed Kotak Mahindra Capital, Nomura and Avendus to manage its proposed $300 million IPO, targeting FY28. Backed by KKR and Norwest…

Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares

Moderna shares plunged after detailed cancer vaccine trial results triggered profit-taking despite reducing melanoma recurrence risk by 42%. Investors weigh commercial prospects, regulatory timelines, and…

Christopher Wood swapped Nvidia for a Greek infrastructure stock. The bet is paying off

Jefferies’ Christopher Wood replaced Nvidia with Greek infrastructure company GEK TERNA in his global long-only equity portfolio in October 2025. Since then, GEK TERNA has…